Key result
Enalapril and captopril reduced erythrocyte oxidant stress and enhanced glutathione-dependent antioxidant defenses in mouse tissues.
Why the study?
Do enalapril and captopril improve glutathione-dependent antioxidant defenses in CF-1 mice?
Do enalapril and captopril improve glutathione-dependent antioxidant defenses in CF-1 mice?
Enalapril and captopril enhance endogenous glutathione-dependent antioxidant defenses and increase nitric oxide production in mouse tissues.
Answers are grounded in this paper and cite their sources.
ACEIs enhance antioxidant defenses in mice; leaves open translation to human CV therapy.
The effect of enalapril and captopril on total glutathione content (GSSG + GSH) and selenium-dependent glutathione peroxidase (Se-GPx) and glutathione reductase (GSSG-Rd) activities was investigated in mouse tissues. CF-1 mice (4-mo-old females) received water containing enalapril (20 mg/l) or captopril (50 mg/l) for 11 wk. Enalapril increased GSSG + GSH content (P < 0.05) in erythrocytes (147%), brain (112%), and lung (67%), and captopril increased GSSG + GSH content in erythrocytes (190%) and brain (132%). Enalapril enhanced Se-GPx activity in kidney cortex (42%) and kidney medulla (23%) and captopril in kidney cortex (30%). GSSG-Rd activity was enhanced by enalapril in erythrocytes (21%), brain (21%), liver (18%), and kidney cortex (53%) and by captopril in erythrocytes (25%), brain (19%), and liver (34%). In vitro erythrocyte oxidant stress was evaluated by thiobarbituric acid-reactive substances (TBARS) production (control 365 +/- 11, enalapril 221 +/- 26, captopril 206 +/- 17 nmol TBARS x g Hb(-1) x h(-1); both P < 0.05 vs. control) and phenylhydrazine-induced methemoglobin (MetHb) formation (control 66.5 +/- 3.5, enalapril 52.9 +/- 0.4, captopril: 56.4 +/- 2.9 micromol MetHb/g Hb; both P < 0.05 vs. control). Both angiotensin-converting enzyme inhibitor treatments were associated with increased nitric oxide production, as assessed by plasma NO-(3) + NO-(2) level determination (control 9.22 +/- 0.64, enalapril 13.7 +/- 1.9, captopril 17.3 +/- 3.0 micromol NO-(3) + NO-(2)/l plasma; both P < 0.05 vs. control). These findings support our previous reports on the enalapril- and captopril-induced enhancement of endogenous antioxidant defenses and include new data on glutathione-dependent defenses, thus furthering current knowledge on the association of ACE inhibition and antioxidants.
No takes yet. Share an insight, caveat, or question.
Cavanagh et al. (2000) studied this question. Enalapril and captopril vs. Control was evaluated on In vitro erythrocyte oxidant stress evaluated by thiobarbituric acid-reactive substances (TBARS) production (p=<0.05). Enalapril and captopril reduced erythrocyte oxidant stress and enhanced glutathione-dependent antioxidant defenses in mouse tissues.
Synapse has enriched 10 related papers. Consider them for comparative context: